Medical Care Technologies Inc Stock Price, News & Analysis

Medical Care Technologies (OTC PINK:MDCE) announced on December 19, 2025 that its first AI-powered mobile application has entered final review stages on both major platforms. The app is in Google Play Console developer testing and has entered Apple App Store official testing, marking a launch milestone as the company prepares for public release.

The application targets the food and nutrition sector as the initial consumer product and is presented as the first step in a broader AI strategy that includes future consumer health, wellness, and medical pre-screening applications under development.

Medical Care Technologies (OTC Pink: MDCE) announced completion of testing for its first AI-based consumer app in the food and nutrition space, which is now under review in the iOS App Store. The company plans a Google Play review before January 1, 2026 and targets launch in 127 countries and 30 languages. Investors will be invited to an exclusive early beta once the app title and theme are released. The company named partnerships with iHeartRadio and app marketing agencies to support the debut. Management highlighted AI-driven change to the business and positioned the app as an early consumer product for the company.

Medical Care Technologies (OTC Pink: MDCE) announced that subsidiaries Real Game Used (RGU) and Infinite Auctions used RGU's patent-pending AI photo-matching to identify and acquire rare, photo-matched memorabilia on the weekend of December 16, 2025.

The company says Infinite Auctions authenticated and secured the items and expects to sell them at a premium, with proceeds intended to support long-term funding for MDCE's AI app development across consumer and healthcare verticals. Management describes the deal as a synergy that will bolster the company's financial foundation and provide resources for continued AI development and marketing.

Medical Care Technologies (OTC Pink: MDCE) completed its first AI-based consumer application, a dietary and nutrition app the company says will be deployed in 100+ countries and made available in 30+ languages. The app enters iOS testing followed by Google Play testing, a process expected to take weeks, with a coordinated marketing launch and name announcement planned after testing.

The company says this consumer launch complements ongoing development of an AI-driven melanoma detection application, whose coding has reached a milestone and whose launch details will be announced later.

Medical Care Technologies (OTC Pink: MDCE) announced a strategic marketing partnership with iHeartRadio on December 11, 2025 to promote MDCE's upcoming health and wellness apps.

The collaboration will use iHeartRadio's network of radio stations, podcasts, and digital channels, citing a reach of over 270 million monthly listeners. MDCE also said it is developing an AI-based digital marketing agency that will launch in 2026 to support its AI applications and promotional efforts.

Medical Care Technologies (OTC PINK:MDCE) announced on December 10, 2025 that its subsidiary Real Game Used (RGU) reached a milestone in sports memorabilia authentication using AI-based pattern recognition and game-used wear detection.

In the past 30 days, RGU authenticated more than 100 premium items with a combined potential value of just over $10 million, highlighting the subsidiary's traction and the company's diversified portfolio.

The release emphasizes RGU's advanced AI-driven processes and notes ongoing work in medical applications at the parent company. For more information, visit realgameused.com and medicalcaretechnologies.com.

Medical Care Technologies (OTC Pink: MDCE) announced increased trading activity and shareholder engagement as of December 9, 2025, citing a stabilization of its share structure after the close of dilution tied to a prior Regulation A offering.

The company highlighted accelerating development of AI health tools, including a Google-backed AI dermatology and wound-monitoring platform for melanoma detection and chronic wound management, plus expanded technical advisory and integration efforts as catalysts for renewed investor interest.

Management said these advances support a path toward consumer testing, commercialization, and long-term revenue execution, and that further updates will follow as execution milestones are reached.

Medical Care Technologies (OTC Pink: MDCE) announced on December 8, 2025 that it has integrated Derm Foundation, a Google-backed pretrained dermatology imaging model, into its soon-to-launch AI wound and skin monitoring mobile platform.

The integration provides melanoma risk classification, chronic-wound progress tracking, data-efficient classification for conditions like psoriasis and dermatitis, automated image-quality checks, and HTTPS API integration for rapid mobile deployment. The company positions the app to enable earlier melanoma detection and reduce preventable hospitalizations by detecting infection risk and wound deterioration from smartphone images.

Company claims note melanoma early-detection survival can reach up to 99% and cite chronic wounds affecting 50 million+ people globally; the app targets rural, underserved and telehealth use cases.

Medical Care Technologies (OTC Pink: MDCE) announced its Regulation A Tier 1 offering will formally conclude on December 6, 2025, ending the dilution period tied to that offering and stopping further share issuance under Reg A.

The company said proceeds from the offering, together with an intentionally lean cost structure, have positioned MDCE to focus on product launches, revenue expansion, and AI innovation throughout 2026. Planned initiatives include a debut consumer-facing nutrition intelligence and recipe generation mobile platform and continued growth of subsidiaries Infinite Auctions and Real Game Used.